Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have received an average rating of “Hold” from the ten ratings firms that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $60.67.

Several equities analysts have recently weighed in on NUS shares. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. BidaskClub downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation raised their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research report on Monday, July 10th. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research report on Wednesday, August 2nd. Finally, Stifel Nicolaus set a $50.00 price target on Nu Skin Enterprises and gave the company a “sell” rating in a report on Thursday, August 3rd.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 7,500 shares of the firm’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total transaction of $456,600.00. Following the completion of the sale, the general counsel now owns 52,230 shares of the company’s stock, valued at $3,179,762.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, President Ryan S. Napierski sold 6,933 shares of the firm’s stock in a transaction on Tuesday, October 10th. The stock was sold at an average price of $64.00, for a total value of $443,712.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 19,040 shares of company stock valued at $1,188,157. Insiders own 5.20% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. increased its stake in Nu Skin Enterprises by 1.8% during the second quarter. BlackRock Inc. now owns 6,805,093 shares of the company’s stock worth $427,632,000 after acquiring an additional 121,562 shares during the last quarter. Vanguard Group Inc. increased its stake in Nu Skin Enterprises by 0.8% during the second quarter. Vanguard Group Inc. now owns 6,060,437 shares of the company’s stock worth $380,838,000 after acquiring an additional 48,805 shares during the last quarter. State Street Corp increased its stake in Nu Skin Enterprises by 76.7% during the first quarter. State Street Corp now owns 1,416,873 shares of the company’s stock worth $78,695,000 after acquiring an additional 614,817 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Nu Skin Enterprises by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 1,067,875 shares of the company’s stock worth $67,106,000 after acquiring an additional 64,767 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Nu Skin Enterprises by 22.1% during the second quarter. Bank of New York Mellon Corp now owns 885,257 shares of the company’s stock worth $55,628,000 after acquiring an additional 160,495 shares during the last quarter. 79.74% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/11/02/nu-skin-enterprises-inc-nus-given-consensus-recommendation-of-hold-by-brokerages.html.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, meeting the consensus estimate of $0.76. The business had revenue of $563.70 million for the quarter, compared to the consensus estimate of $562.70 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. The business’s quarterly revenue was down 6.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.98 earnings per share.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Friday, November 17th will be issued a $0.36 dividend. The ex-dividend date is Thursday, November 16th. This represents a $1.44 annualized dividend and a dividend yield of 2.26%. Nu Skin Enterprises’s dividend payout ratio is presently 48.81%.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.